TheranosBusinessInside the Exclusive Nathan Fielder InterviewBy Brian Barrett, Zoë Schiffer, and Leah FeigerThe Big StoryThe Story of Billy Evans and ‘Theranos 2.0’By Christopher HooksThe Big StoryHow Elizabeth Holmes Tricked WIRED—and Everyone ElseBy Adam RogersCultureThe New Fan’s Guide to the Unreal World of Nathan FielderBy Miles KleeCultureTV Struggles to Put Silicon Valley on the ScreenBy Arielle PardesBusinessPut the System That Enabled Elizabeth Holmes on TrialBy Steven LevyIdeasThe Elizabeth Holmes Verdict and the Legal Loophole for 'Disruption'By Noam CohenBusinessTheranos Founder Elizabeth Holmes Is Convicted on 4 CountsBy Arielle PardesBusinessElizabeth Holmes Speaks for HerselfBy Arielle PardesBusinessElizabeth Holmes Is on Trial. Silicon Valley Is WatchingBy Arielle PardesIdeasClubhouse Cured My Imposter SyndromeBy C. Brandon OgbunuCultureHellboy Could Get Shazam!-ed at the Box OfficeBy Angela WatercutterCultureThe Inventor, Theranos, and Multiplatform SchadenfreudeBy Peter RubinIdeasElizabeth Holmes’ Downfall Has Been Explained Deeply—By MenBy Virginia HeffernanBusinessThe Theranos Indictments Expose the Soul of Silicon ValleyBy Brian BarrettThe Big StoryA Look Inside Theranos’ Dysfunctional Corporate CultureBy John CarreyrouScienceTheranos Didn't Nuke the Diagnostics BusinessBy Adam RogersBusinessTheranos and Tech's 'Fake It Till You Make It' CultureBy Erin GriffithScienceWhat Biotech CEOs (and Their Funders) Learned From TheranosBy Adam RogersBusiness2016 Was the Year Silicon Valley's Hype Machine SputteredBy Cade MetzScienceTheranos Blew It. But It Didn't Ruin Biotech Startups for EveryoneBy Megan MolteniScienceTheranos Gives Up on Blood-Testing Labs to Become the Thing It Tried to FixBy Nick StocktonScienceTheranos Had a Chance to Clear Its Name. Instead, It Tried to PivotBy Nick StocktonScienceThe 9 Fiascos That Have Pretty Much Doomed TheranosBy Nick StocktonMore Stories
-w.jpg)
